Ogata M, Umakoshi H, Fukumoto T, Matsuda Y, Yokomoto-Umakoshi M, Nagata H, Wada N, Miyazawa T, Sakamoto R, Ogawa Y; Q-AND-A Study Group. “Significance of aldosterone gradient within left adrenal vein in diagnosing unilateral subtype of primary aldosteronism”. Clin Endocrinol (Oxf). 2020, doi: 10.1111/cen.14320, [Epub ahead of print].

Yokomoto-Umakoshi M, Umakoshi H, Sakamoto R, Fukumoto T, Ogata M, Nakano Y, Iwahashi N, Kaneko H, Mizoguchi N, Hattori A, Miyazawa T, Matsuda Y, Kawate H, Ogawa Y; Q-AND-A study group. “Role of deteriorated bone quality in the development of osteoporosis in pheochromocytoma and paraganglioma”. Bone. 2020, doi: 10.1016/j.bone.2020.115607, [Epub ahead of print].

Kaneko H, Umakoshi H, Ishihara Y, Nanba K, Tsuiki M, Kusakabe T, Satoh-Asahara N, Yasoda A, Tagami T. “Reassessment of urinary aldosterone measurement after saline infusion in primary aldosteronism”. Journal of Endocr Soc.4(9): 1-8, 2020.

Yokomoto-Umakoshi M, Umakoshi H, Ogata M, Fukumoto T, Matsuda Y, Miyazawa T, Sakamoto R, Ogawa Y, Q-AND-A study group. “Coexistence of Osteoporosis and Atherosclerosis in Pheochromocytoma: New Insights Into Its Long-Term Management” Osteoporos Int. 2020, doi: 10.1007/s00198-020-05527-5, [Epub ahead of print].

Yokomoto-Umakoshi M, Umakoshi H, Fukumoto T, Matsuda Y, Nagata H, Ogata M, Kawate H, Miyazawa T, Sakamoto R, Ogawa Y, Q-AND-A study group. “Pheochromocytoma and Paraganglioma: an Emerging Cause of Secondary Osteoporosis” Bone. 2020, doi: 10.1016/j.bone.2020.115221, [Epub ahead of print].

Yokomoto-Umakoshi M, Sakamoto R,  Umakoshi H, Matsuda Y, Nagata H, Fukumoto T, Ogata M, Sakamoto R, and Ogawa Y, the Q-AND-A study group. “Unilateral Primary Aldosteronism as an Independent Risk Factor for Vertebral Fracture” Clin Endocrinol (Oxf). 91(6): 737-742, 2020.

Umakoshi H, Sakamoto R, Matsuda Y, Yokomoto-Umakoshi, M, Nagata H, Fukumoto T, Ogata M, and Ogawa Y, the Q-AND-A study group. “Role of Aldosterone and Potassium Levels in Sparing Confirmatory Tests in Primary Aldosteronism”. J Clin Endocrinol Metab. 105(4): 1284-1289, 2020.

Fujii Y, Takeda Y, Kurihara I, Ito H, Katabami T, Ichijo T, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Yamamoto K, Ogo A, Yanase T, Okamura S, Miyauchi S, Fujita M, Suzuki T, Umakoshi H, Ogasawara T, Tsuiki M, and Naruse M, “Historical changes and between-facility differences in adrenal venous sampling for primary aldosteronism in Japan”. J hum Hypertens. 34(1): 34-42, 2020.

Kaneko H, Umakoshi H, Ishihara Y, Sugawa T, Nanba K, Tsuiki M, Kusakabe T, Satoh-Asahara N, Yasoda A, Tagami T.“Seated Saline Infusion Test in Predicting Subtype Diagnosis of Primary Aldosteronism” Clin Endocrinol (Oxf). 91(6): 737-742, 2019.

Tagami T, Hiroshima-Hamanaka K, Umakoshi H, Tsuiki-Naruse M, Kusakabe T, Satoh-Asahara N, Shimatsu A, Moriyama K. “Experimental reproduction of dynamic fluctuation of TSH receptor-binding antibodies between stimulation and inhibition” Journal of Endocr Soc. 3(12): 2361-2373, 2019

Kawashima A, Sone M, Inagaki N, Takeda Y, Itoh H Kurihara I, Umakoshi H, Ichijo T, Katabami T, Wada N, Ogawa Y, Kawashima J, Fujita M, Miyauchi S, Okamura S, Fukuoka T, Yanase T, Izawa S, Yoshikawa Y, Hashimoto S, Yamada M, Kai T, Naruse M ;JPAS and JPAS Study group. “Renal Impairment is Closely Associated with Plasma Aldosterone Concentration in Patients with Primary Aldosteronism”. Eur J Endocrinol. 181(3): 339-350, 2019.

Takeda Y, Umakoshi H, Takeda Y, Yoneda T, Kurihara I, Katabami T, Ichijo T, Wada N, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Takahashi K, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamto K, Ogo A, Yanase T, Suzuki T, Naruse M; JPAS Study Group. Impact of adrenocorticotropic hormone stimulation during adrenal venous sampling on outcomes of primary aldosteronism. J Hypertens. 37(7): 1493-1499, 2019.

Akehi Y, Yanase T, Motonaga R, Umakoshi H, Tsuiki M, Takeda Y, Yoneda T, Kurihara I, Itoh H, Katabami T, Ichijo T, Wada N, Shibayama Y, Yoshimoto T, Ashida K, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamoto K, Ogo A, Okamura S, Miyauchi S, Fukuoka T, Izawa S, Hashimoto S, Yamada M, Yoshikawa Y, Kai T, Suzuki T, Kawamura T, Naruse M; Japan Primary Aldosteronism Study Group. “High Prevalence of Diabetes in Patients With Primary Aldosteronism (PA) Associated With Subclinical Hypercortisolism and Prediabetes More Prevalent in Bilateral Than Unilateral PA: A Large, Multicenter Cohort Study in Japan”. Diabetes Care. 42(5): 938-945, 2019.

Nagasawa M, Yamamoto K, Rakugi H, Takeda M, Akasaka H, Umakoshi H, Tsuiki M, Takeda Y, Kurihara I, Itoh H, Ichijo T, Katabami T, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Ogo A, Okamura S, Miyauchi S, Yanase T, Suzuki T, Kawamura T, Naruse M; JPAS Study Group. “Influence of antihypertensive drugs in the subtype diagnosis of primary aldosteronism by adrenal venous sampling.” J Hypertens. 37(7): 1493-1499, 2019.

Minamoto-Higashioka M, Kawamura R, Umakoshi H, Yokomoto-Umakoshi M, Utsunomiya D, Osawa H, Kondo S. “Seasonal Variation in Severe Glucose-lowering Drug-induced Hypoglycemia in Patients with Type 2 Diabetes.” Intern Med. 58(8): 1067-1072, 2019.

Ishihara Y, Sugawa T, Kaneko H, Hiroshima-Hamanaka K, Amano A, Umakoshi H, Tsuiki M, Kusakabe T, Satoh-Asahara N, Shimatsu A, Tagami T. "The Delayed Diagnosis of Thyroid Storm in Patients with Psychosis: A Report of Two Cases". Intern Med. 58(15): 2195-2199, 2019.

Umakoshi H, Tsuiki M, Takeda Y, Kurihara I, Itoh H, Katabami T, Ichijo T, Wada N, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Watanabe M, Yuichi M, Kobayashi H, Shibata H, Kamemura K Otsuki M, Fujii Y, Yamamto K, Ogo A, Yanase T, Suzuki T, Naruse M. “Significance of Computed Tomography and Serum Potassium in Predicting Subtype Diagnosis of Primary Aldosteronism.” J Clin Endocrinol Metab. 103(3): 900-908, 2018.

Umakoshi H, Ogasawara T, Takeda Y, Kurihara I, Itoh H, Katabami T, Ichijo T, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamto K, Ogo A, Yanase T, Okamura S, Miyauchi S, Suzuki T, Tsuiki M, Naruse M. “Accuracy of adrenal computed tomography in predicting the unilateral subtype in young patients with hypokalaemia and elevation of aldosterone in primary aldosteronism. Clin Endocrinol (Oxf). 88(5): 645-651, 2018.

Umakoshi H, Tsuiki M, Yokomoto-Umakoshi M, Takeda Y, Yoneda T, Kurihara I, Itoh H, Katabami T, Ichijo T, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamto K, Ogo A, Yanase T, Okamura S, Miyauchi S, Fukuoka T, Izawa S, Yanase T, Hashimoto S, Yamada M, Yoshikawa Y, Kai T, Suzuki T, Kawamura T, Naruse M. “Correlation Between Lateralization Index of Adrenal Venous Sampling and Standardized Outcome in Primary Aldosteronism.” Journal of Endocr Soc. 2(8): 893-902, 2018.

Shibayama Y, Wada N, Naruse M, Kurihara I, Ito H, Yoneda T, Takeda Y, Umakoshi H, Tsuiki M, Ichijo T, Fukuda H, Katabami T, Yoshimoto T, Ogawa Y, Kawashima J, Ohno Y, Sone M, Fujita M, Takahashi K, Shibata H, Kamemura K, Fujii Y, Yamamoto K, Suzuki T. “The Occurrence of Apparent Bilateral Aldosterone Suppression in Adrenal Vein Sampling for Primary Aldosteronism.” Journal of Endocr Soc. 2(5): 398-407, 2018.

Yokomoto-Umakoshi M, Umakoshi H, Tsuiki M, Ogasawara T, Hamanaka-Hiroshima K, Tanabe A, Tagami T, Shimatsu A, Naruse M. “Paraganglioma as a risk factor for bone metastasis.” Endocr J. 65(3): 253-260, 2018.

Ohno Y, Sone M, Inagaki N, Yamasaki T, Ogawa O, Takeda Y, Kurihara I, Itoh H, Umakoshi H, Tsuiki M, Ichijo T, Katabami T, Tanaka Y, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Takahashi K, Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamoto K, Ogo A, Okamura S, Miyauchi S, Fukuoka T, Izawa S, Yoneda T, Hashimoto S, Yanase T, Suzuki T, Kawamura T, Tabara Y, Matsuda F, Naruse M; Nagahama Study; JPAS Study Group. “Prevalence of Cardiovascular Disease and Its Risk Factors in Primary Aldosteronism: A Multicenter Study in Japan.” Hypertension. 71(3): 530-537, 2018.

Williams TA, Burrello J, Sech L, Fardella C, Matrozova J, Baudrand C, Bernardi S, Beuschlein F, Catena C, Doumas M, Fallo F, Giacchetti G, Heinrich D, Saint-Hilary G, Jansen P, Januszewicz A, Kocjan T, Nishikawa T, Quinkler M, Satoh F, Umakoshi H, Widimský J, Hahner S, Douma S, Stowasser M, Mulatero P, Reincke M. “Computed Tomography and Adrenal Venous Sampling in the Diagnosis of Unilateral Primary Aldosteronism.” Hypertension. 72(3): 641-649, 2018.

Kobayashi H, Abe M, Soma M, Takeda Y, Kurihara I, Itoh H, Umakoshi H, Tsuiki M, Katabami T, Ichijo T, Wada N, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Watanabe M, Yuichi M, Shibata H, Kamemura K, Yanase T, Otsuki M, Fujii Y, Yamamto K, Ogo A, Nanba K, Tanabe A, Suzuki T, Naruse M. “Development and validation of subtype prediction scores for the workup of primary aldosteronism.” J Hypertension. 36(11): 2269-2276, 2018.

Takeda M, Yamamoto K, Akasaka H, Rakugi H, Naruse M, Takeda Y, Kurihara I, Itoh H, Umakoshi H, Tsuiki M, Ichijo T, Katabami T, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Ogo A, Okamura S, Miyauchi S, Yanase T, Suzuki T, Kawamura T; JPAS Study Group. “Clinical characteristics and postoperative outcomes of primary aldosteronism in the elderly.” J Clin Endocrinol Metab. 103(10): 3620-3629, 2018.

Ohno Y, Sone M, Inagaki N, Yamasaki T, Ogawa O, Takeda Y, Kurihara I, Umakoshi H, Ichijo T, Katabami T, Wada N, Ogawa Y, Yoshimoto T, Kawashima J, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Miyauchi S, Kamemura K, Fukuoka T, Yamamoto K, Otsuki M, Suzuki T, Naruse M; JPAS Study Group. “Obesity as a key factor underlying idiopathic hyperaldosteronism.” J Clin Endocrinol Metab. 103(12): 4456-4464, 2018.

Umakoshi H, Yang X, Ichijo T, Kamemura K, Matsuda Y, Fujii Y, Kai T, Fukuoka T, Sakamoto R, Ogo A, Suzuki T, Ogasawara T, Tsuiki M, Naruse M. “Reassessment of the cosyntropin stimulation test in the confirmatory diagnosis and subtype classification of primary aldosteronism.” Clin Endocrinol (Oxf). 86(2): 170-176, 2017.

Williams TA, Lenders JWM, Mulatero P, Burrello J, Rottenkolber M, Adolf C, Satoh F, Amar L, Quinkler M, Deinum J, Beuschlein F, Kitamoto KK, Pham U, Morimoto R, Umakoshi H, Prejbisz A, Kocjan T, Naruse M, Stowasser M, Nishikawa T, Young WF Jr, Gomez-Sanchez CE, Funder JW, Reincke M. “Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort.” Lancet Diabetes Endocrinol. 5(9): 689-699, 2017.

Fujii Y, Umakoshi H, Wada N, Ichijo, Kamemura K, Matsuda Y, Kai T, Fukuoka T, Sakamoto R, Ogo A, Suzuki T Nanba K Tsuiki M Naruse M.“Subtype prediction of primary aldosteronism by combining aldosterone concentrations in the left adrenal vein and inferior vena cava: a multicenter collaborative study on adrenal venous sampling.” J hum Hypertens. 32(1): 12-19, 2017.

Kamemura K, Wada N, Ichijo T, Matsuda Y, Fujii Y, Kai T, Fukuoka T, Sakamoto R, Ogo A, Suzuki T, Umakoshi H, Tsuiki M, Naruse M. “Significance of adrenal computed tomography in predicting laterality and indicating adrenal vein sampling in primary aldosteronism.” J hum Hypertens. 31(3): 195-199, 2017.

Wada N, Shibayama Y, Umakoshi H, Ichijo T, Fujii Y, Kamemura K, Kai T, Sakamoto R, Ogo A, Matsuda Y, Fukuoka T, Tsuiki M, Suzuki T, Naruse M. “Hyperkalemia in both surgically and medically treated patients with primary aldosteronism.” J hum Hypertens. 31(10): 627-632, 2017.

Naruse M, Umakoshi H, Tsuiki M, Yokomoto M, Tagami T, Tanabe A, Shimatsu A. “The Latest Developments of Functional Molecular Imaging in the Diagnosis of Primary Aldosteronism.” Horm Metab Res. 49(12): 929-935, 2017.

Umakoshi H, Naruse M, Wada N, Ichijo T, Kamemura K, Matsuda Y, Fujii Y, Kai T, Fukuoka T, Sakamoto R, Ogo A, Suzuki T, Nanba K, Tsuiki M. “Adrenal Venous Sampling in Patients With Positive Screening but Negative Confirmatory Testing for Primary Aldosteronism.” Hypertension. 67(5): 1014-1019, 2016.

Shibayama Y, Wada N, Umakoshi H, Wada N, Ichijo T, Kamemura K, Matsuda Y, Fujii Y, Kai T, Fukuoka T, Sakamoto R, Ogo A, Suzuki T, Tsuiki M, Naruse M. “Bilateral aldosterone suppression and its resolution in adrenal vein sampling of patients with primary aldosteronism: analysis of data from the WAVES-J study.” Clin Endocrinol (Oxf). 85(5): 696-702, 2016.

Umakoshi H, Tanase-Nakao K, Wada N, Ichijo T, Sone M, Inagaki N, Katabami T, Kamemura K, Matsuda Y, Fujii Y, Kai T, Fukuoka T, Sakamoto R, Ogo A, Suzuki T, Tsuiki M, Shimatsu A, Naruse M. “Optimum position of left adrenal vein sampling for subtype diagnosis in primary aldosteronism.” Clin Endocrinol (Oxf). 83(6): 768-73, 2015.

Umakoshi H, Wada N, Ichijo T, Kamemura K, Matsuda Y, Fujii Y, Kai T, Fukuoka T, Sakamoto R, Ogo A, Suzuki T, Tsuiki M, Naruse M. “Importance of contralateral aldosterone suppression during adrenal vein sampling in the subtype evaluation of primary aldosteronism.” Clin Endocrinol (Oxf). 83(4): 462-7, 2015.

Nanba K, Tsuiki M, Umakoshi H, Nanba A, Hirokawa Y, Usui T, Tagami T, Shimatsu A, Suzuki T, Tanabe A, Naruse M. “Shortened saline infusion test for subtype prediction in primary aldosteronism.” Endocrine. 50(3): 802-6, 2015.

Yokomoto M, Minamoto M, Utsunomiya D, Umakoshi H, Fukuoka T, Kondo S. “Hypercalcemic crisis due to primary hyperparathyroidism occurring concomitantly with Graves' disease.” IIntern Med.54(7): 813-818, 2015.

Tanase-Nakao K, Naruse M, Nanba K, Tsuiki M, Tagami T, Usui T, Okuno H, Shimatsu A, Hashimoto S, Katabami T, Ogo A, Okumura A, Umakoshi H, Suzuki T. “Chronic kidney disease score for predicting postoperative masked renal insufficiency in patients with primary aldosteronism.” Clin Endocrinol (Oxf). 81(5): 665-70, 2014.

馬越洋宜. “原発性アルドステロン症”. 内科, 124巻6号:2463-2468 2019年.

馬越洋宜, “原発性アルドステロン症の診断と治療の進歩”. BIO Clinica, 8巻2号:120-122, 2019年.

馬越洋宜, 成瀬光栄, 田上哲也. “副腎皮質癌の最新の知見”. 臨床泌尿器科, 72巻6号 484-489, 2018年.

馬越洋宜. “原発性アルドステロン症における新規病型診断法の確立”. Medical Science Digest, 44巻5号：245-247, 2018年.

馬越洋宜, 横本真希, 立木美香, 田上哲也, 成瀬光栄. “原発性アルドステロン症の局在診断法としての副腎静脈サンプリングの課題”. 血圧 , 24巻12号: 858-860, 2017年.

馬越洋宜, 田上哲也. “原発性アルドステロン症”. Medicina, 53巻13号: 2203-2207, 2016年.

馬越洋宜, 和田典男, 一城貴政, 松田祐一, 亀村幸平, 福岡富和, 藤井雄一, 甲斐達也, 坂本竜一, 小河淳, 鈴木知子, 小笠原辰樹, 難波多挙, 立木美香, 成瀬光栄. “原発性アルドステロン症の病型診断における副腎静脈サンプリングの課題”. 日本内分泌・甲状腺外科学会雑誌32巻4号：220-224,2016年.

馬越洋宜, 立木美香、成瀬光栄, ”副腎がん“. What’s New in Oncology 、改訂第4版, 南山堂328-334, 2019年.

馬越洋宜, 田上哲也, 成瀬光栄. “原発性アルドステロン症の成因”. 原発性アルドステロン症診療マニュアル改定第3版, 42-44, 2017年.

馬越洋宜, 立木美香, 成瀬光栄 . “副腎がん”. What’s New in Oncology  改訂第3版, 南山堂, 2015年.

馬越洋宜（編集協力）患者さんのための原発性アルドステロン症 Q&A, 診断と治療社, 2014年.